Old Web
English
Sign In
Acemap
>
authorDetail
>
Hironori Harada
Hironori Harada
Juntendo University
Cancer research
Biology
Genetics
EZH2
RUNX1
3
Papers
120
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Upregulation of Bcl-2 Confers Resistance to FLT3 Inhibition in FLT3 -ITD AML with Secondary Acquired Mutations
2018
Blood
Kotoko Yamatani
Yoko Tabe
Kaori Saito
Haeun Yang
Yuko Murakami-Tonami
Koya Suzuki
Weiguo Zhang
Sonoko Kinjo
Kazuho Ikeo
Kaoru Mogushi
Masaki Hosoya
Shigeo Yamaguchi
Hironori Harada
Takashi Miida
Neil P. Shah
Marina Konopleva
Yoshihide Hayashizaki
Michael Andreeff
Show All
Source
Cite
Save
Citations (3)
Combined Targeting of Bcl-2 and XPO1 Overcomes Acquired Resistance to Tyrosine Kinase Inhibitors in the FLT3-ITD/TKD Double Mutant AML
2018
Blood
Yoko Tabe
Kotoko Yamatani
Haeun Yang
Kaori Saito
Yuko Murakami-Tonami
Koya Suzuki
Weiguo Zhang
Sonoko Kinjo
Kazuho Ikeo
Masaki Hosoya
Kaoru Mogushi
Shigeo Yamaguchi
Hironori Harada
Takashi Miida
Neil Shah
Marina Konopleva
Yoshihide Hayashizaki
Michael Andreeff
Show All
Source
Cite
Save
Citations (1)
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
2014
Nature Communications
Goro Sashida
Hironori Harada
Hirotaka Matsui
Motohiko Oshima
Makiko Yui
Yuka Harada
Satomi Tanaka
Makiko Mochizuki-Kashio
Changshan Wang
Atsunori Saraya
Tomoya Muto
Yoshihiro Hayashi
Kotaro Suzuki
Hiroshi Nakajima
Toshiya Inaba
Haruhiko Koseki
Gang Huang
Toshio Kitamura
Atsushi Iwama
Show All
Source
Cite
Save
Citations (116)
1